Serveur d'exploration Tocilizumab - Checkpoint (Ncbi)

Index « Auteurs » - entrée « Masashi Narazaki »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Masashi Naito < Masashi Narazaki < Masashi Takaso  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 18.
Ident.Authors (with country if any)Title
000189 (2010) Atsushi Ogata [Japon] ; Masahide Mori ; Shoji Hashimoto ; Yukihiro Yano ; Takeya Fujikawa ; Mari Kawai ; Yusuke Kuwahara ; Toru Hirano ; Junsuke Arimitsu ; Keisuke Hagihara ; Yoshihito Shima ; Masashi Narazaki ; Souichirou Yokota ; Tadamitsu Kishimoto ; Ichiro Kawase ; Toshio TanakaMinimal influence of tocilizumab on IFN-gamma synthesis by tuberculosis antigens.
000194 (2009) Toshio Tanaka [Japon] ; Yusuke Kuwahara ; Yoshihito Shima ; Toru Hirano ; Mari Kawai ; Masako Ogawa ; Junsuke Arimitsu ; Keisuke Hagihara ; Masashi Narazaki ; Atsushi Ogata ; Ichiro Kawase ; Tadamitsu KishimotoSuccessful treatment of reactive arthritis with a humanized anti-interleukin-6 receptor antibody, tocilizumab.
000198 (2010) Toshio Tanaka ; Keisuke Hagihara ; Yoshihito Shima ; Masashi Narazaki ; Atsushi Ogata ; Ichiro Kawase ; Tadamitsu KishimotoTreatment of a patient with remitting seronegative, symmetrical synovitis with pitting oedema with a humanized anti-interleukin-6 receptor antibody, tocilizumab.
000283 (2010) Yoshihito Shima [Japon] ; Yusuke Kuwahara ; Hiroyuki Murota ; Shun Kitaba ; Mari Kawai ; Toru Hirano ; Junsuke Arimitsu ; Masashi Narazaki ; Keisuke Hagihara ; Atsushi Ogata ; Ichiro Katayama ; Ichiro Kawase ; Tadamitsu Kishimoto ; Toshio TanakaThe skin of patients with systemic sclerosis softened during the treatment with anti-IL-6 receptor antibody tocilizumab.
000308 (2010) Toshio Tanaka [Japon] ; Atsushi Ogata ; Masashi NarazakiTocilizumab for the treatment of rheumatoid arthritis.
000309 (2011) Atsushi Ogata ; Atsuyoshi Morishima ; Toru Hirano ; Yoshihiro Hishitani ; Keisuke Hagihara ; Yoshihito Shima ; Masashi Narazaki ; Toshio TanakaImprovement of HbA1c during treatment with humanised anti-interleukin 6 receptor antibody, tocilizumab.
000338 (2011) Sumiyuki Nishida [Japon] ; Tomio Kawasaki ; Hirokazu Kashiwagi ; Atsuyoshi Morishima ; Yoshihiro Hishitani ; Mari Kawai ; Toru Hirano ; Taeko Ishii ; Keisuke Hagihara ; Yoshihito Shima ; Masashi Narazaki ; Atsushi Ogata ; Yoshihiro Oka ; Tadamitsu Kishimoto ; Toshio TanakaSuccessful treatment of acquired hemophilia A, complicated by chronic GVHD, with tocilizumab.
000367 (2011) Toshio Tanaka [Japon] ; Masashi Narazaki ; Tadamitsu KishimotoAnti-interleukin-6 receptor antibody, tocilizumab, for the treatment of autoimmune diseases.
000382 (2011) Masashi Narazaki ; Keisuke Hagihara ; Yoshihito Shima ; Atsushi Ogata ; Tadamitsu Kishimoto ; Toshio TanakaTherapeutic effect of tocilizumab on two patients with polymyositis.
000414 (2012) Toru Hirano [Japon] ; Nobuyuki Ohguro ; Satoshi Hohki ; Keisuke Hagihara ; Yoshihito Shima ; Masashi Narazaki ; Atsushi Ogata ; Kazuyuki Yoshizaki ; Atsushi Kumanogoh ; Tadamitsu Kishimoto ; Toshio TanakaA case of Behçet's disease treated with a humanized anti-interleukin-6 receptor antibody, tocilizumab.
000452 (2012) Toshio Tanaka [Japon] ; Masashi Narazaki ; Tadamitsu KishimotoTherapeutic targeting of the interleukin-6 receptor.
000A37 (2015) Yoshihito Shima [Japon] ; Naoki Hosen ; Toru Hirano ; Junsuke Arimitsu ; Sumiyuki Nishida ; Keisuke Hagihara ; Masashi Narazaki ; Atsushi Ogata ; Toshio Tanaka ; Tadamitsu Kishimoto ; Atsushi KumanogohExpansion of range of joint motion following treatment of systemic sclerosis with tocilizumab.
000A48 (2014) Toshio Tanaka [Japon] ; Masashi Narazaki [Japon] ; Atsushi Ogata [Japon] ; Tadamitsu Kishimoto [Japon]A new era for the treatment of inflammatory autoimmune diseases by interleukin-6 blockade strategy.
000B94 (2014) Toshio Tanaka [Japon] ; Masashi Narazaki [Japon] ; Tadamitsu Kishimoto [Japon]IL-6 in inflammation, immunity, and disease.
001246 (2016) Toshio Tanaka [Japon] ; Masashi Narazaki [Japon] ; Tadamitsu Kishimoto [Japon]Immunotherapeutic implications of IL-6 blockade for cytokine storm.
001574 (2017) Masashi Narazaki [Japon] ; Toshio Tanaka [Japon] ; Tadamitsu Kishimoto [Japon]The role and therapeutic targeting of IL-6 in rheumatoid arthritis.
001685 (2018) Toshio Tanaka [Japon] ; Masashi Narazaki [Japon] ; Tadamitsu Kishimoto [Japon]Interleukin (IL-6) Immunotherapy.
001C82 (2018) Masashi Narazaki [Japon] ; Tadamitsu Kishimoto [Japon]The Two-Faced Cytokine IL-6 in Host Defense and Diseases.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Ncbi/Checkpoint
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/Author.i -k "Masashi Narazaki" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/Author.i  \
                -Sk "Masashi Narazaki" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Checkpoint/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    Ncbi
   |étape=   Checkpoint
   |type=    indexItem
   |index=    Author.i
   |clé=    Masashi Narazaki
}}

Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021